You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

Claims for Patent: 6,448,231

✉ Email this page to a colleague

« Back to Dashboard

Summary for Patent: 6,448,231

Title:	Method and compositions for the treatment of cerebral palsy
Abstract:	The invention provides for the use of a presynaptic neurotoxin (for example a bacterial neurotoxin such as botulinum toxin B) for the manufacture of a medicament for the treatment of cerebral palsy in juvenile patients. The juvenile patients are preferably juveniles of up to 6 years in age.
Inventor(s):	Graham; Herbert Kerr (Lisburn, GB)
Assignee:	Allergan, Inc. (Irvine, CA)
Application Number:	09/900,380
Patent Claims:	1. A method for treating juvenile cerebral palsy, the method comprising the step of administering a therapeutically effective amount of a botulinum toxin type B to a juvenile cerebral palsy patient, thereby treating juvenile cerebral palsy. 2. The method of claim 1, wherein the botulinum toxin is administered intramuscularly. 3. The method of claim 1, wherein the botulinum toxin is administered subcutaneously. 4. The method of claim 1, wherein the botulinum toxin is administered into a spastic muscle. 5. The method of claim 1, wherein the amount of the botulinum toxin type B is from about 80 units of botulinum toxin to about 460 units of the botulinum toxin type B. 6. The method of claim 1, wherein the amount of the botulinum toxin type B is at least 500 units of the botulinum toxin type B. 7. The method of claim 6, wherein the amount of the botulinum toxin type B is at least 1000 units of the botulinum toxin type B. 8. A method of treating juvenile cerebral palsy, the method comprising the step of administering at least 1000 units of a botulinum toxin type B to a juvenile cerebral palsy patient, thereby treating juvenile cerebral palsy.

Details for Patent 6,448,231

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Solstice Neurosciences, Llc	MYOBLOC	rimabotulinumtoxinb	Injection	103846	12/08/2000	⤷ Try a Trial	2011-09-24
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.